Yazid Al Hamarneh

Yazid Al Hamarneh serves as Assistant Professor at the University of Alberta, holding dual leadership roles as Scientific Officer of the Alberta SPOR SUPPORT Unit and Associate Director of the Epicore Centre. His work bridges academic research with practical healthcare implementation in community pharmacy settings.

His academic credentials include:

• BSc Pharmacy from the University of Jordan
• PhD in Clinical Pharmacy and Pharmacy Practice from Queen’s University, Belfast
• Postdoctoral Fellowship in Cardiology and Research Methods at the University of Alberta

Dr. Al Hamarneh's research focuses on revolutionizing chronic disease management through pharmacist-led interventions, with particular expertise in cardiovascular disease prevention and control. His work drives the paradigm shift toward patient-centered pharmacy practice, emphasizing community-based solutions for hypertension, diabetes, and cardiovascular risk factors. Key methodologies include implementation science frameworks and real-world effectiveness studies that translate research into actionable clinical tools.

Analysis of his 2016-2022 publications reveals three dominant trajectories: (1) Development of practice tools like RXING for diabetes management, (2) Expansion of pharmacist roles during crises (notably the INSPIRE Survey on pandemic impacts), and (3) Rigorous evaluation of cardiovascular interventions through the landmark RxEACH trial across diverse populations including CKD patients. His work consistently demonstrates how pharmacist prescribing improves outcomes while addressing cost-effectiveness and patient perspectives.

Through the Epicore Centre and Alberta SPOR SUPPORT Unit, he shapes health research infrastructure by mentoring researchers, developing methodology standards, and facilitating patient-oriented research networks. His leadership enables evidence translation into provincial healthcare policies, particularly for chronic disease management in underserved communities.